Alniditan, a new 5-HYdroxytryptamine1D agonist and migraine-abortive agent: Ligand-binding properties of human 5-hydroxytryptamine1Dα, human 5-Hydroxytryptamine1Dβ, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan

Molecular Pharmacology

Volumn 50, Issue 6, 1996, Pages 1567-1580

  Leysen, José E ^a   Gommeren, Walter ^a   Heylen, Lieve ^a   Luyten, Walter H M L ^a   Van De Weyer, Inez ^a   Vanhoenacker, Peter ^b   Haegeman, Guy ^b   Schotte, Alain ^a   Van Gompel, Paul ^a   Wouters, Ria ^a   Lesage, Anne S ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ALNIDITAN; ANTIMIGRAINE AGENT; BENZOPYRAN DERIVATIVE; COMPLEMENTARY DNA; DIHYDROERGOTAMINE; KETANSERIN; METHYSERGIDE; OCAPERIDONE; RADIOLIGAND; RECEPTOR SUBTYPE; RISPERIDONE; RITANSERIN; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1D RECEPTOR; SUMATRIPTAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CATTLE; CELL LINE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

ANIMALS; BENZOPYRANS; CATTLE; CLONING, MOLECULAR; GLIOMA; HELA CELLS; HUMANS; MICE; MIGRAINE DISORDERS; PROPYLAMINES; PROTEIN BINDING; PYRIMIDINES; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SIGNAL TRANSDUCTION; TRITIUM; TUMOR CELLS, CULTURED; VASOCONSTRICTOR AGENTS;

EID: 0030447893     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. 1D-agonists Bioorg. Med. Chem. Lett. 5:2649-2654 (1995).
2. Van de Water, A., J. D'Aubioul, W. Van Gerven, K. Van Ammel, and F. De Clerck. Selective vasoconstriction by alniditan in the carotid vascular bed of anaesthetized dogs. Eur. J. Pharmacol. 299:127-137 (1996).
3. 1D-receptor agonist: a s.c. dose-finding trial, in Proceedings of the 6th International Headache Research Seminar: Headache Treatment, Trial Methodology and New Drugs. (1995).
4. Humphrey, P. P. A., and W. Feniuk. Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol. Sci. 12:444-446 (1991).
5. Saxena, P. R., and M. O. Den Boer. Pharmacology of anti-migraine drugs. J. Neurol. 238:S28-S35 (1991).
6. 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J. Neurosci. 7:894-903 (1987).
7. 1 receptors in the vertebrate brain: regional distribution examined by autoradiography. Naunyn-Schmiedeberg's Arch. Pharmacol. 340:486-494 (1989).
8. 1D receptor: a progress review. Neurochem. Res. 15:567-582 (1990).
9. 1D binding sites in human and guinea-pig brain using different radioligands. Mol. Brain Res. 21:19-29 (1994).
10. Hoyer, D., and D. N. Middlemiss. Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol. Sci. 10:130-132 (1989).
11. 1D-receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra. Naunyn-Schmiedeberg's Arch. Pharmacol. 337:602-608 (1988).
12. Middlemiss, D. N. Blockade of the central 5-HT autoreceptor by β-adrenoceptor antagonists. Eur. J. Pharmacol. 120:51-56 (1986).
13. 1D subtype. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:371-377 (1990).
14. 1D subtype. Br. J. Pharmacol. 102:191-197 (1991).
15. 1D-like receptors, and a comparison with grafted veins. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:500-508 (1992).
16. 1Dβ" receptors. Eur. J. Pharmacol. 242:75-82 (1993).
17. Buzzi, M. G., W. B. Carter, T. Shimizu, H. Heath III, and M. A. Moskowitz. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 30:1193-1200 (1991).
18. 1D receptor genes. Trends Pharmacol. Sci. 13:152-159 (1992).
19. Hoyer, D., D. E. Clarke, J. R. Fozard, P. R. Hartig, G. R. Martin, E. J. Mylecharane, P. R. Saxena, and P. A. Humphrey. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:157-203 (1994).
20. 1D-type serotonin receptor. Mol. Pharmacol. 40:143-148 (1991).
21. 1B receptor. J. Biol. Chem. 267:5735-5738 (1992).
22. 1D subtype. J. Biol. Chem. 267:7553-7562 (1992).
23. 1Dβ. Proc. Natl. Acad. Sci. USA 89:3630-3634 (1992).
24. 1D serotonin receptor. Biochem. Biophys. Res. Commun. 180:1460-1498 (1991).
25. 1Dα receptor. Abstr. Soc. Neurosci. 21:442.3 (1995).
26. 1Dβ receptors. FEBS Lett. 377:73-76 (1995).
27. 1D serotonin receptors in rat: structural and pharmacological comparison of the two cloned receptors. Mol. Cell. Neurosci. 8:578-587 (1992).
28. 1Dβ receptor. Mol. Pharmacol. 41:1-7 (1992).
29. 355 Asn site directed mutagenesis. Biochem. Pharmacol. 44: 1917-1920 (1992).
30. 1B receptors. Nature (Lond.) 360:161-163 (1992).
31. 3H-labelled R 91274 at high specific activity, in J. R. F. Non-clinical Pharmacokinetics Report. Janssen Pharmaceutica, Beerse, Belgium, N99382 (1993).
32. 2-receptors, a promising tracer for γ-emission tomography. J. Labelled Compd. Radiopharm. 34:795-806 (1994).
33. Schotte, A., P. F. M. Janssen, W. Gommeren, W. H. M. L. Luyten, P. Van Gompel, A. S. Lesage, K. De Loore, and J. E. Leysen. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124:57-73 (1996).
34. Vanhoenacker, P., W. Gommeren, W. H. M. L. Luyten, J. E. Leysen, and G. Haegeman. Stable, high-level of human serotonin receptors in L929 cells using an inducible expression system. Recept. Channels, in press.
35. Chen, C., and H. Okayama. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752 (1987).
36. Hug, H., M. Costas, P. Staeheli, M. Aebi, and C. Weissmann. Organization of the murine Mx gene and characterization of its Interferon- and virus-inducible promoter. Mol. Cell. Biol. 8:3065-3079 (1988).
37. Lleonart, R., D. Näf, H. Browning, and C. Weissmann. A novel, quantitative bioassay for type 1 Interferon using a recombinant indicator cell line. Biotechnology (N. Y.) 8:1263-1267 (1990).
38. Oestreicher, E. G., and G. F. Pinto. A microcomputer program for fitting enzyme inhibition rate equations. Comput. Biol. Med. 17:317-321 (1987).
39. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108 (1973).
40. 1A receptors occupied by 5HT or 8-OH-DPAT to adenylyl cyclase. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:367-374 (1992).
41. 1Dβ receptor subtype in human and bovine cerebral arteries. Mol. Pharmacol. 44:242-246 (1993).
42. Moekowitz, M. A. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci. 13:307-311 (1991).
43. 1Dα serotonin receptor gene expression in trigeminal ganglia: implication for antimigraine drug development. Proc. Natl. Acad. Sci. USA 91:3666-3669 (1994).
44. 3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin-and tetrabenazine-like drugs. J. Pharmacol. Exp. Ther. 244:310-321 (1988).
45. 1D-like sites in guinea pig brain. Eur. J. Pharmacol. 205:323-324 (1991).
46. 1D binding sites in bovine substantia nigra. Br. J. Pharmacol. 109:1206-1211 (1993).
47. 1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:263-275 (1995).
48. 1Dβ-receptor in pig caudate membranes. Eur. J. Pharmacol. 264:213-216 (1994).
49. 1D binding sites. J. Neurochem. 58:951-959 (1992).
50. 7 receptor in rat brain. Br. J. Pharmacol. 117:657-666 (1996).
51. 1D binding sites in various species: similar pharmacological profile in dog, monkey, calf, guinea pig and human brain membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:243-248 (1992).
52. 1D binding sites. J. Pharmacol. Exp. Ther. 259:1360-1365 (1991).
53. 1Dβ receptor subtypes. Eur. J. Pharmacol. 291:9-15 (1995).
54. Leysen, J. E., P. M, F. Janssen, W. Gommeren, J. Wynants, P. J. Pauwels, and P. A. J. Janssen. In vitro and in vivo receptor binding and effect on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone. Mol. Pharmacol. 41:494-508 (1992).
55. 1Dβ-receptor subtype in human cortex. Eur. J. Pharmacol. 242:195-198 (1993).
56. 1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33:367-386 (1994).